MedPath

Drumming Lessons' Influence on Children With Down Syndrome

Not Applicable
Not yet recruiting
Conditions
Down Syndrome
Registration Number
NCT07156318
Lead Sponsor
Vanderbilt University
Brief Summary

The goal of this clinical trial is to learn if drumming lessons can increase self-control in children with Down syndrome. The main question it aims to answer is whether 2 months of drumming lessons can improve the behavioral control and timing skills in children with Down syndrome. Participants are between 7 and 15 years of age and receive two months of drumming lessons given by a professional drummer with extensive experience working with children with Down syndrome. Children in the experimental group visit our lab once before lessons start and once after lessons are completed. Children in the control group visit our lab twice before they start their lessons. Lab visits include brain recordings taken using a net-style cap, computer tasks, and drumming to music.

Detailed Description

Down syndrome (DS) is the most common chromosomal cause of cognitive disability, and it affects approximately 1 in 700 live births. Although the genetic etiology of DS (a complete or partial third 21st chromosome) has been known for over 50 years, many fundamental questions about how to support high quality of life for individuals with DS remain unanswered. One area of relative weakness in DS is Inhibitory Control (IC). This skill is important for daily tasks such as following directions, making decisions, and managing money among other tasks. Existing research demonstrates a clear link between playing the drums and IC. In the proposed research, we will conduct an experiment in which 7- to 12-year-old children are randomly assigned to the Experimental (EXP) and Wait List Control (WLC) conditions. In the EXP condition, children will receive drumming lessons between Visit 1 and Visit 2, and in the Wait List Control group, children will receive drumming lessons after Visit 2. In this way, all children will receive drumming lessons, but only the EXP group will show effects of the drumming lessons in Visit 2. Testing conducted during Visits 1 and 2 will include behavioral and neural measures of inhibitory control and drumming, neural measures of beat perception, and parent report of social behavior (via Standardized questionnaire). Our predictions are that children in the EXP condition will show improvements in both measures of IC and increases in precision in the beat perception and drumming tasks. We also expect that parent report of children's behavior on the social skills questionnaire will show improvement. Across the EXP and WLC conditions, we expect no differences at Visit 1 but significant differences between conditions at Visit 2.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Down syndrome
Exclusion Criteria
  • Already taken drumming lessons
  • Uncorrected hearing loss
  • Uncorrected vision loss

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Zoo taskBaseline to two months

Behavioral "Go/No go" task done on a computer designed to assess children's inhibitory control

Statue taskBaseline to two months

Child is encouraged to 'become a statue' by holding their body in a position and not moving

Beat PerceptionBaseline to two months

EEG measure of brain activity during passive listening to music

Beat productionBaseline to two months

EEG and behavioral measures of when child thinks beat is happening during music or metronome

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Vanderbilt University

🇺🇸

Nashville, Tennessee, United States

Vanderbilt University
🇺🇸Nashville, Tennessee, United States
Caroline Danforth, MS
Contact
615-343-1079
vuhandsonplaylab@gmail.com
Alison Rubin, BA
Contact
615-343-1079
vuhandsonplaylab@gmail.com
Amy Needham, PhD
Principal Investigator
Miriam Lense, PhD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.